Age, y | n | Prevalence per year(%) | P value* | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ìý | Ìý | 2019 | 2020 | 2021 | 2022 | 2023 | Ìý | Ìý | ||||||
Ìý | Ìý | M | H | M | H | M | H | M | H | M | H | M | H | |
6 | 13,752 | 19.7 | 1.4 | 31.3# | 1.2 | 27.6 | 2.2 | 17.7 | 1.9 | 13.2 | 1.1 |  &±ô³Ù; 0.001 |  &±ô³Ù; 0.001 | |
7 | 13,556 | 31.9 | 0.9 | 42.1 | 1.8 | 43.0# | 1.5 | 29.1 | 1.8 | 27.8 | 1.1 |  &±ô³Ù; 0.001 |  &±ô³Ù; 0.001 | |
8 | 13,192 | 47.6 | 1.7 | 53.7# | 1.3 | 53.5 | 1.3 | 40.2 | 1.4 | 41.0 | 1.0 |  &±ô³Ù; 0.001 | 0.103 | |
9 | 14,172 | 52.7 | 1.7 | 64.1 | 1.1 | 67.8# | 1.2 | 51.4 | 1.6 | 52.2 | 1.1 |  &±ô³Ù; 0.001 | 0.033 | |
10–11 | 12,547 | 66.7 | 0.9 | 71.8 | 1.3 | 72.8# | 1.3 | 62.1 | 1.0 | 63.1 | 0.7 |  &±ô³Ù; 0.001 | 0.004 | |
12–13 | 11,866 | 72.5 | 0.8 | 77.1 | 1.0 | 81.9# | 1.2 | 66.5 | 1.1 | 70.4 | 0.8 |  &±ô³Ù; 0.001 | 0.063 |